Kwivik Therapeutics is a medtech platform company that has developed a robust pipeline of novel products to disrupt certain respiratory, emergency medical, asthma, migraine/cluster headache, wound care and skin care markets globally.
Kwivik Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for Kwivik Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
